If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Proof of Concept Programme

11 Dec 2007 11:18

Imperial Innovations Group plc11 December 2007 Imperial Innovations Group plc ("Imperial Innovations") Proof of Concept programme Imperial Innovations Group plc (AIM: IVO) today announces the creation of a newUS$1 million Proof of Concept ("PoC") programme which has been funded byShapoorji Pallonji & Company Limited ("SPCL") a diversified conglomerateincluding the oldest construction company based in India. The objective of the PoC programme is to validate and accelerate the developmentof emerging technologies at Imperial College London for spin-out opportunities.Imperial Innovations will manage the programme including the recommendation,selection, and commercial assessment of the projects. The company isparticularly interested in developing technologies with SPCL which may lead tomarket applications and follow-on joint development opportunities in India. The PoC programme will fund three to five technologies of twelve to eighteenmonths' duration over the next two years and will give priority to applicationsin the built environment, whether renewable energy or energy-efficiencyinnovations. The creation of the PoC programme with SPCL builds on Imperial Innovations'ongoing activities in India which is regarded as one of the most importanttechnology markets for the future, including the recent formation of i2india,the technology commercialisation company based in India. Susan Searle, CEO of Imperial Innovations said: "The launch of the Shapoorji Proof of Concept programme will help us qualifyinventions in our intellectual property portfolio for more focused spin-outopportunities. Pre-commercial funding is very difficult to obtain forearly-stage technologies therefore we are extremely grateful for the fundingSPCL has provided. We are also encouraged that influential companies such asSPCL turn to us to access next generation technologies." Mr. Pallonji Mistry, Chairman of Shapoorji Pallonji & Co. Ltd., Mumbai said: "We look forward to a mutually rewarding and long term relationship withImperial Innovations through promoting development projects in selected areas." -Ends- For more information contact: Imperial InnovationsSusan Searle, Chief Executive Officer +44 (0)20 7594 6591Lucy Ahfong, Marketing Communications Executive +44 (0)20 7594 6644 M:CommunicationsPatrick d'Ancona / Eleanor Williamson +44 (0)20 7153 1539 JPMorgan Cazenove (NOMAD to Imperial Innovations)Steve Baldwin +44(0)20 7588 2828 Notes to Editors About Imperial Innovations Imperial Innovations is one of the UK's leading technology transfer andcommercialisation companies. The company was founded in 1986 and its ordinaryshares admitted to trading on the AIM Market of London Stock Exchange plc inJuly 2006, raising £25 million at an offer price of 365p and £1 million by meansof a public offer. In November 2007, the company raised a further £30 million bymeans of a placing of new ordinary shares with investors. The company's integrated approach encompasses the identification of ideas,protection of intellectual property, development and licensing of technology andformation, incubation and investment in technology businesses. A wide range oftechnologies are commercialised within the areas of healthcare, energy,environment and emerging technology trends. Based at Imperial College London, the company has established equity holdings in74 technology businesses and is managing 133 commercial agreements as of 31 July2007. Imperial Innovations also commercialises technologies originating fromoutside Imperial College through incubation contracts with the Carbon Trust andWRAP and has commercialisation contracts with a number of multinationalcorporations including BAE Systems. www.imperialinnovations.co.uk About Shapoorji Pallonji & Company Ltd Shapoorji Pallonji & Company Ltd is a diversified conglomerate with businessinterests in the construction, finance, biotechnology, and energy sectors. Thecompany started 140 years ago in Mumbai as a construction company. ShapoorjiPallonji has grown from its origins as India's oldest construction company andhas developed an international reputation in delivering complex projectsincluding factories, nuclear research establishments, nuclear waste handling,scientific and research establishments, stadia and auditoria, airports, hotels,hospitals, giant skyscrapers, housing complexes, townships, water treatmentplants, roads, expressways, power plants and biotech facilities. It is thelargest private shareholder (18.5%) of TATA SONS Ltd, the Holding Company of theTATA Group. The annual turnover of the TATA Group is over US$15 billion. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Oct 20077:24 amPRNGBP30m Placing
27th Sep 20077:04 amRNSInvestment in EVO Electric
27th Sep 20077:00 amPRNFinal Results
24th Sep 20072:44 pmRNSThe Engineer Awards
12th Sep 20078:00 amPRNNotice of Preliminary Results
31st Aug 20079:00 amRNSInvestment in MVL
7th Aug 20079:00 amRNSionscope raises funds
3rd Aug 200710:25 amRNSInvestment in Veryan Medical
3rd Aug 20078:00 amRNSInvestment in Veryan Medical
1st Aug 20075:31 pmRNSInvestment in Nexeon Ltd
30th Jul 20078:00 amRNSInvestment in Acrobot Ltd
11th Jul 20079:37 amRNSInvestment in AML
6th Jul 20078:10 amRNSInvestment in NanoBioDesign
28th Jun 20077:02 amRNSInvestment in QuantaSol
25th Jun 200710:00 amRNSCall For Recycling Inventions
20th Jun 200711:21 amRNSInvestment in PolyTherics
14th Jun 20072:31 pmRNSInvestment in Midaz Lasers
6th Jun 20073:11 pmRNSPSE Wins MacRobert Award
5th Jun 200711:03 amRNSPSE - Awards Finalist
23rd May 20078:00 amRNSInvestment in IXICO Ltd
11th May 200710:00 amRNSInvestment in Veryan Medical
9th May 200710:04 amRNSMDi Licensing Deal
27th Apr 20077:01 amRNSLaunch of Funding Programme
27th Apr 20077:01 amRNSInterim Results
30th Mar 20078:00 amRNSInvestment in Cell Medica
27th Mar 200710:22 amRNSStormBio Licensing Deal
23rd Mar 20078:00 amRNSNotice of Results
22nd Mar 200711:53 amRNSHolding(s) in Company
16th Mar 200710:44 amRNSHolding(s) in Company
15th Mar 20079:00 amRNSIncubation of Stoneglass
12th Mar 20078:00 amRNSIonscope Sells First Products
8th Mar 20079:20 amRNSHolding(s) in Company
7th Mar 20078:00 amRNSChinese Strategic Partnership
13th Feb 20078:00 amRNSIncubation of Rubber-Regen
9th Feb 20073:05 pmRNSHolding(s) in Company
8th Feb 20072:58 pmRNSHolding(s) in Company
1st Feb 20077:00 amRNSInvestment in ATT Ltd
29th Jan 20077:01 amRNSInvestment in Circassia
25th Jan 200712:59 pmRNSResult of AGM
12th Jan 20079:00 amRNSInvestment in Equinox Pharma
21st Dec 200612:13 pmRNSTotal Voting Rights
18th Dec 20064:53 pmRNSHolding(s) in Company
8th Dec 20067:00 amRNSAnnual Report and Accounts
21st Nov 20067:01 amRNSDirector/PDMR Shareholding
16th Nov 20067:01 amRNSBAE Systems Contract
16th Nov 20067:01 amRNSFinal Results
2nd Nov 20068:00 amRNSImperial BioIncubator
26th Oct 20067:01 amRNSNotice of Results
23rd Oct 20064:17 pmRNSDisposal
18th Oct 20067:00 amRNSLow Carbon Seed Fund

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.